Acquisition extends Resonant's European footprint and adds specialized calibration expertise,

此次收购扩大了 Resonant 在欧洲的业务布局，并增添了专业的校准技术专长。

IOR/EOR reach, and partner depots to support the clinical trial lifecycle at global scale

IOR/EOR 覆盖范围，以及支持全球规模临床试验生命周期的合作伙伴仓库

LEESBURG, Va.

弗吉尼亚州利斯堡

,

，

Sept. 30, 2026

2026年9月30日

/PRNewswire/ -- Resonant Clinical Solutions ('Resonant'), a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle, today announced that it has acquired Germany-based labfish rental solutions Gmbh ('Labfish') and its U.S. and U.K.

/美通社/ -- 全球临床解决方案合作伙伴 Resonant Clinical Solutions（“Resonant”）服务于生命科学组织，覆盖临床供应链和样本生命周期，今日宣布已收购总部位于德国的 labfish rental solutions Gmbh（“Labfish”）及其在美国和英国的业务。

affiliates, which together provide end-to-end clinical and laboratory rental equipment and calibration solutions. The acquisition expands Resonant's Equipment & Ancillaries (E&A) presence in Europe and strengthens its ability to support increasingly complex clinical trial programs around the world with high-demand, specialized capabilities..

附属公司，共同提供端到端的临床和实验室租赁设备及校准解决方案。此次收购扩大了 Resonant 公司在欧洲的设备与辅助产品（E&A）业务布局，并增强了其凭借高需求的专业能力支持全球日益复杂的临床试验项目的能力。

Based in Hamburg, Germany, Labfish offers a broad inventory of laboratory equipment for rent — including scales, freezers, refrigerators, infusion pumps, and monitors — alongside kitting, ancillary supplies, and industry-leading in-house calibration expertise. Labfish also provides Importer of Record (IOR)/Exporter of Record (EOR) and white-glove direct-to-patient logistics management, working with partner depots in Argentina, Israel, Turkey, and China to supply clinical trial sites in more than 70 countries.

Labfish 总部位于德国汉堡，提供广泛的实验室设备租赁服务，包括天平、冷冻箱、冰箱、输液泵和监护仪等，同时还提供配套套件、辅助用品以及行业领先的内部校准专业服务。Labfish 还提供登记进口商（IOR）/登记出口商（EOR）服务以及高端直达患者的物流管理，并与阿根廷、以色列、土耳其和中国的合作伙伴仓库协同工作，为全球70多个国家的临床试验站点提供供应支持。

Originally founded in 2014, Labfish is ISO 9001-certified and operates one of the largest in-house calibration facilities serving clinical trials in Europe..

Labfish 成立于2014年，拥有ISO 9001认证，并运营着欧洲服务于临床试验的最大的内部校准设施之一。

'Incorporating Labfish into Resonant's E&A business extends our presence in Europe and deepens our calibration and import/export services, further enhancing the world-class clinical trial solutions our customers depend on,' said Christophe Berthoux, Chief Executive Officer, Resonant Clinical Solutions.

Resonant Clinical Solutions 首席执行官 Christophe Berthoux 表示：“将 Labfish 纳入 Resonant 的 E&A 业务，扩展了我们在欧洲的业务布局，并深化了我们的校准和进出口服务，从而进一步提升客户所依赖的世界级临床试验解决方案。”

'This acquisition builds on the success of our Equipment & Ancillaries business to meet the rapidly evolving needs of our customers. The capabilities Labfish brings to Resonant advances our strategy to support more of the clinical journey at global scale.'.

“此次收购在我们设备与辅助用品业务的成功基础上，进一步满足客户快速变化的需求。Labfish为Resonant带来的能力推进了我们的战略，以在全球范围内支持更多的临床旅程。”

Increasingly complex clinical trial programs demand specialized equipment, calibration, and logistics support that keep pace with evolving research protocols, workflows, and requirements. To meet this need, the Labfish acquisition complements Resonant's existing E&A business, providing client partners with a robust offering and technical expertise in Europe as their development programs scale..

日益复杂的临床试验项目需要专用设备、校准和物流支持，以跟上不断演变的研究方案、工作流程和需求。为满足这一需求，对 Labfish 的收购补充了 Resonant 现有的设备与分析（E&A）业务，在客户合作伙伴的开发项目规模扩大时，为其提供强大的产品组合和欧洲地区的专业技术支持。

'Joining Resonant allows our team to further grow the calibration expertise, warehouse network, and import/export and logistics services we've spent years developing, now with the capabilities to support more of the clinical trial journey,' said Martin Forster, Founder, Labfish. 'We're excited to bring our technical knowledge, strategic services, and valued customer relationships to Resonant.'.

“加入 Resonant 使我们的团队能够进一步拓展我们多年来打造的校准专业能力、仓储网络以及进出口与物流服务，如今我们更有能力支持临床试验旅程的更多环节，” Labfish 创始人 Martin Forster 表示。“我们很高兴将我们的技术知识、战略服务以及珍贵的客户关系带到 Resonant。”

Financial terms of the transaction were not disclosed.

交易的财务条款未予披露。

About Resonant Clinical Solutions

关于 Resonant Clinical Solutions

Resonant Clinical Solutions is a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle. Through its Biorepository, Kitting, and Equipment & Ancillaries businesses, Resonant helps customers manage complexity, reduce risk, and support critical clinical programs around the world.

Resonant Clinical Solutions 是一家全球临床解决方案合作伙伴，服务于生命科学组织在临床供应链和样本生命周期中的各个环节。通过其生物样本库、配套试剂盒以及设备与辅助用品业务，Resonant 帮助客户管理复杂性、降低风险，并支持全球关键临床研究项目。

With more than 850 employees across the U.S., U.K., and Europe, Resonant manages more than 100 million research assets in storage, and has supported more than 2,500 clinical trials and facilitated more than 20,000 customer-site shipments. The company serves pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and diagnostic and reference laboratories..

Resonant 在美国、英国和欧洲拥有超过 850 名员工，管理着超过 1 亿项研究资产存储，支持了超过 2,500 项临床试验，并促成了超过 20,000 次客户现场发货。该公司服务于制药和生物技术公司、合同研究组织（CRO）、合同开发与制造组织（CDMO）以及诊断和参考实验室。

Resonant's mission is to empower its partners with comprehensive, global clinical supply chain and sample lifecycle solutions that remove complexity and enable them to focus on science and patients. For more information, visit

Resonant 的使命是通过提供全面的全球临床供应链和样本生命周期解决方案，赋能合作伙伴，消除复杂性，使其能够专注于科学研究和患者服务。欲了解更多信息，请访问

resonantclinical.com.

resonantclinical.com

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示